SAN || Psoriasis

Early psoriatic arthritis treatment with etanercept gives better outcomes

Posted on: 18/01/2015 - 18:54

Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial. Patients with...

Field of Interest: Dermatology

Type: News Item

Early psoriatic arthritis treatment with etanercept gives better outcomes

Posted on: 18/01/2015 - 18:54

Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial. Patients with...

Field of Interest: Rheumatology

Type: News Item

Annual costs of psoriasis costs top $112 billion

Posted on: 07/01/2015 - 16:00

The total economic burden of psoriasis in the United States is at least $112 billion per year, and possibly as high as $135 billion, investigators est... More »

Field of Interest: Dermatology

Type: News Item

Secukinumab tames psoriatic arthritis in FUTURE 2 trial

Posted on: 07/12/2014 - 19:50

BOSTON – Secukinumab improved quality of life and symptoms in patients with psoriatic arthritis, regardless of whether they had received prior anti-tumor-necrosis factor therapy or were concurrently...

Field of Interest: Rheumatology

Type: News Item

Few psoriatic arthritis patients achieve minimal disease activity on methotrexate

Posted on: 05/12/2014 - 16:16

BOSTON – It’s time to test whether methotrexate is really up to snuff as a first-line therapy for psoriatic arthritis, Canadian investigators say. They base that recommendation on findings from a...

Field of Interest: Rheumatology

Type: News Item

TNF-alpha blockers effective in sustaining reduced PsA activity

Posted on: 05/12/2014 - 16:02

A state of minimal disease activity in patients with psoriatic arthritis is sustainable over several years by using treatments with tumor necrosis factor–alpha blockers, according to findings from a...

Field of Interest: Rheumatology

Type: News Item

Oral curcumin shown effective in psoriasis

Posted on: 10/11/2014 - 15:35

AMSTERDAM – Oral curcumin proved safe and effective as adjunctive therapy in patients on topical corticosteroids for mild to moderate psoriasis vulgaris in a 12-week, randomized, placebo-controlled...

Field of Interest: Dermatology

Type: News Item

Chronic inflammatory disease patients at greater risk of major CV events

Posted on: 07/11/2014 - 16:45

Patients with rheumatoid arthritis, psoriatic arthritis, or psoriasis are at an increased risk of major adverse cardiovascular events when compared with the general population, according to findings...

Field of Interest: Dermatology

Type: News Item

Chronic inflammatory disease patients at greater risk of major CV events

Posted on: 07/11/2014 - 16:45

Field of Interest: Rheumatology

Type: News Item

Apremilast succeeds against nail, scalp, palmoplantar psoriasis

Posted on: 03/11/2014 - 19:36

LAS VEGAS – A twice-daily 30-mg dose of apremilast significantly improved moderate to severe nail, scalp, and palmoplantar psoriasis, compared with placebo, based on data from 411 adults in the...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters